Dr. McLoughlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2301 Erwin Rd
Durham, NC 27710Phone+1 919-684-8111Fax+1 919-684-8111
Education & Training
- University of ColoradoResidency, Surgery, 2013 - 2018
- Wayne State University School of MedicineClass of 2014
Certifications & Licensure
- NC State Medical License 2023 - 2025
- NY State Medical License 2021 - 2024
- CO State Medical License 2016 - 2023
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- 19 citationsBile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1Yuan Xu, Deborah R. Surman, Laurence P. Diggs, Sichuan Xi, Shaojian Gao
Oncogene. 2020-01-23 - 19 citationsInduction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma.Paul L. Feingold, Deborah R. Surman, Katherine A. Brown, Yuan Xu, Lucas A. McDuffie
Molecular Cancer Therapeutics. 2018-09-01 - 16 citationsASXL3 is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung CancerVivek Shukla, Mahadev Rao, Hongen Zhang, Jeanette Beers, Darawalee Wangsa
Cancer Research. 2017-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: